Li Q - Search Results

1

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma.

Cui Y, Chen Z, Pan B, Chen T, Ding H, Li Q, Wan L, Luo G, Sun L, Ding C, Yang J, Tong X, Zhao J. Cui Y, et al. Among authors: li q. Front Cell Dev Biol. 2022 Sep 13;10:979262. doi: 10.3389/fcell.2022.979262. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36176276 Free PMC article.

2

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma.

Yang J, Luo G, Li C, Zhao Z, Ju S, Li Q, Chen Z, Ding C, Tong X, Zhao J. Yang J, et al. Among authors: li c, li q. BMC Cancer. 2022 May 30;22(1):589. doi: 10.1186/s12885-022-09685-z. BMC Cancer. 2022. PMID: 35637432 Free PMC article.

3

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response.

Yang J, Chen Z, Gong Z, Li Q, Ding H, Cui Y, Tang L, Li S, Wan L, Li Y, Ju S, Ding C, Zhao J. Yang J, et al. Among authors: li s, li y, li q. Front Genet. 2022 May 11;13:908104. doi: 10.3389/fgene.2022.908104. eCollection 2022. Front Genet. 2022. PMID: 35646074 Free PMC article.

4

Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma.

Gong Z, Li Q, Yang J, Zhang P, Sun W, Ren Q, Tang J, Wang W, Gong H, Li J. Gong Z, et al. Among authors: li j, li q. Front Bioeng Biotechnol. 2022 May 12;10:852734. doi: 10.3389/fbioe.2022.852734. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35646872 Free PMC article.

5

Tang Y, Li Q, Zhang D, Ma Z, Yang J, Cui Y, Zhang A. Tang Y, et al. Among authors: li q. Front Genet. 2022 Sep 14;13:977156. doi: 10.3389/fgene.2022.977156. eCollection 2022. Front Genet. 2022. PMID: 36186452 Free PMC article.

6

Preoperative systemic immune-inflammation index for predicting the prognosis of thymoma with radical resection.

Li Q, Pu Y, Gong Z, Yu Y, Sun W, Cheng Z, Wang W, Zhao J. Li Q, et al. Thorac Cancer. 2023 May;14(13):1192-1200. doi: 10.1111/1759-7714.14854. Epub 2023 Mar 23. Thorac Cancer. 2023. PMID: 36951114 Free PMC article.

7

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.

Zeng W, Wang J, Yang J, Chen Z, Cui Y, Li Q, Luo G, Ding H, Ju S, Li B, Chen J, Xie Y, Tong X, Liu M, Zhao J. Zeng W, et al. Among authors: li q, li b. Front Immunol. 2023 Jul 7;14:1217590. doi: 10.3389/fimmu.2023.1217590. eCollection 2023. Front Immunol. 2023. PMID: 37492563 Free PMC article.

8

Single-cell and Bulk RNA-Seq reveal angiogenic heterogeneity and microenvironmental features to evaluate prognosis and therapeutic response in lung adenocarcinoma.

Tang L, Chen Z, Yang J, Li Q, Wang S, Mo T, Zeng W, Ding H, Pan S. Tang L, et al. Among authors: li q. Front Immunol. 2024 Feb 8;15:1352893. doi: 10.3389/fimmu.2024.1352893. eCollection 2024. Front Immunol. 2024. PMID: 38390340 Free PMC article.

9

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients.

Shao CY, Yu Y, Li QF, Liu XL, Song HZ, Shen Y, Yi J. Shao CY, et al. Front Oncol. 2021 Sep 2;11:736573. doi: 10.3389/fonc.2021.736573. eCollection 2021. Front Oncol. 2021. PMID: 34540700 Free PMC article.

10

A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma.

Gong Z, Li Q, Li J, Xie J, Wang W. Gong Z, et al. Among authors: li j, li q. Transl Cancer Res. 2022 Jan;11(1):14-28. doi: 10.21037/tcr-21-1554. Transl Cancer Res. 2022. PMID: 35261881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,395 results

Search Page

Filters